Christina Guzzo, Ph.D. - Publications

Affiliations: 
2012 Microbiology & Immunology Queen's University, Canada, Kingston, Ontario, Canada 
Area:
Immunology, Microbiology Biology, Virology Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Petes C, Wynick C, Guzzo C, Mehta D, Logan S, Banfield BW, Basta S, Cooper A, Gee K. IL-27 enhances LPS-induced IL-1β in human monocytes and murine macrophages. Journal of Leukocyte Biology. PMID 28377398 DOI: 10.1189/Jlb.3A0316-098R  1
2016 Cimbro R, Peterson FC, Liu Q, Guzzo C, Zhang P, Miao H, Van Ryk D, Ambroggio X, Hurt DE, De Gioia L, Volkman BF, Dolan MA, Lusso P. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry. Ebiomedicine. PMID 27389109 DOI: 10.1016/J.Ebiom.2016.06.037  1
2015 Fox JC, Tyler RC, Guzzo C, Tuinstra RL, Peterson FC, Lusso P, Volkman BF. Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation. Acs Chemical Biology. PMID 26302421 DOI: 10.1021/Acschembio.5B00542  1
2015 Guzzo C, Fox JC, Miao H, Volkman BF, Lusso P. Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1. Journal of Virology. PMID 26085164 DOI: 10.1128/Jvi.01285-15  1
2015 Sironi F, Malnati M, Mongelli N, Cozzi P, Guzzo C, Ghezzi S, Martínez-Romero C, García-Sastre A, Lusso P, Jabes D, Biswas P. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains. Journal of Translational Medicine. 13: 107. PMID 25888743 DOI: 10.1186/S12967-015-0461-9  1
2014 Cimbro R, Gallant TR, Dolan MA, Guzzo C, Zhang P, Lin Y, Miao H, Van Ryk D, Arthos J, Gorshkova I, Brown PH, Hurt DE, Lusso P. Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 111: 3152-7. PMID 24569807 DOI: 10.1073/Pnas.1314718111  1
2013 Guzzo C, Fox J, Lin Y, Miao H, Cimbro R, Volkman BF, Fauci AS, Lusso P. The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1. Plos Pathogens. 9: e1003852. PMID 24385911 DOI: 10.1371/Journal.Ppat.1003852  1
2013 Wiener R, DiBello AT, Lombardi PM, Guzzo CM, Zhang X, Matunis MJ, Wolberger C. E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1. Nature Structural & Molecular Biology. 20: 1033-9. PMID 23955022 DOI: 10.1038/Nsmb.2655  0.72
2012 Gambhir V, Yildiz C, Mulder R, Siddiqui S, Guzzo C, Szewczuk M, Gee K, Basta S. The TLR2 agonists lipoteichoic acid and Pam3CSK4 induce greater pro-inflammatory responses than inactivated Mycobacterium butyricum. Cellular Immunology. 280: 101-7. PMID 23298864 DOI: 10.1016/J.Cellimm.2012.12.001  1
2012 Guzzo C, Jung M, Graveline A, Banfield BW, Gee K. IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. Scientific Reports. 2: 974. PMID 23240078 DOI: 10.1038/Srep00974  1
2012 Guzzo C, Hopman WM, Che Mat NF, Wobeser W, Gee K. IL-27-induced gene expression is downregulated in HIV-infected subjects. Plos One. 7: e45706. PMID 23049843 DOI: 10.1371/Journal.Pone.0045706  1
2012 Guzzo C, Ayer A, Basta S, Banfield BW, Gee K. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. Journal of Immunology (Baltimore, Md. : 1950). 188: 864-73. PMID 22156348 DOI: 10.4049/Jimmunol.1101912  1
2012 Guzzo C, Mat NFC, Gee K. Interleukin-27 induces a STAT1/3- and NF-κB-dependent proinflammatory cytokine profile in human monocytes (Journal of Biological Chemistry (2010) 285 (24404-24411) DOI: 10.1074/jbc.A110.112599) Journal of Biological Chemistry. 287: 8661. DOI: 10.1074/jbc.A110.112599  1
2011 Abdulkhalek S, Amith SR, Franchuk SL, Jayanth P, Guo M, Finlay T, Gilmour A, Guzzo C, Gee K, Beyaert R, Szewczuk MR. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling. The Journal of Biological Chemistry. 286: 36532-49. PMID 21873432 DOI: 10.1074/Jbc.M111.237578  1
2011 Che Mat NF, Zhang X, Guzzo C, Gee K. Interleukin-23-induced interleukin-23 receptor subunit expression is mediated by the Janus kinase/signal transducer and activation of transcription pathway in human CD4 T cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 31: 363-71. PMID 21138378 DOI: 10.1089/Jir.2010.0083  1
2010 Finlay TM, Abdulkhalek S, Gilmour A, Guzzo C, Jayanth P, Amith SR, Gee K, Beyaert R, Szewczuk MR. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo. Glycoconjugate Journal. 27: 583-600. PMID 20697956 DOI: 10.1007/S10719-010-9302-5  1
2010 Guzzo C, Che Mat NF, Gee K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. The Journal of Biological Chemistry. 285: 24404-11. PMID 20519510 DOI: 10.1074/Jbc.M110.112599  1
2010 Guzzo C, Hopman WM, Che Mat NF, Wobeser W, Gee K. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. Aids (London, England). 24: 1371-4. PMID 20375875 DOI: 10.1097/Qad.0B013E3283391D2B  1
2010 Finlay TM, Jayanth P, Amith SR, Gilmour A, Guzzo C, Gee K, Beyaert R, Szewczuk MR. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9. Glycoconjugate Journal. 27: 329-48. PMID 20213245 DOI: 10.1007/S10719-010-9281-6  1
2009 Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflammation & Allergy Drug Targets. 8: 40-52. PMID 19275692 DOI: 10.2174/187152809787582507  1
Show low-probability matches.